688639 华恒生物
已收盘 05-15 15:00:01
资讯
新帖
简况
每周股票复盘：华恒生物（688639）推进H股上市进程
证券之星 · 05-10
每周股票复盘：华恒生物（688639）推进H股上市进程
华恒生物（688639）披露发行H股并上市进展公告，5月6日股价下跌1.07%
证券之星 · 05-06
华恒生物（688639）披露发行H股并上市进展公告，5月6日股价下跌1.07%
每周股票复盘：华恒生物（688639）每股派现0.16元（含税）
证券之星 · 05-02
每周股票复盘：华恒生物（688639）每股派现0.16元（含税）
新股消息 | 华恒生物(688639.SH)递表港交所
智通财经 · 05-01
新股消息 | 华恒生物(688639.SH)递表港交所
每周股票复盘：华恒生物（688639）股东户数减少13.68%，一季报净利降17.61%
证券之星 · 04-26
每周股票复盘：华恒生物（688639）股东户数减少13.68%，一季报净利降17.61%
华恒生物（688639）2026年一季报简析：增收不增利，公司应收账款体量较大
证券之星 · 04-24
华恒生物（688639）2026年一季报简析：增收不增利，公司应收账款体量较大
华恒生物(688639.SH)发布一季度业绩，归母净利润4210万元，同比下降17.61%
智通财经 · 04-23
华恒生物(688639.SH)发布一季度业绩，归母净利润4210万元，同比下降17.61%
新股消息 | 华恒生物(688639.SH)港股IPO获中国证监会备案
智通财经网 · 04-10
新股消息 | 华恒生物(688639.SH)港股IPO获中国证监会备案
华恒生物（688639）披露2025年年度持续督导跟踪报告，4月7日股价上涨2.96%
证券之星 · 04-07
华恒生物（688639）披露2025年年度持续督导跟踪报告，4月7日股价上涨2.96%
每周股票复盘：华恒生物（688639）获准发行H股
证券之星 · 04-05
每周股票复盘：华恒生物（688639）获准发行H股
华恒生物（688639）披露2025年度股东会会议资料，4月3日股价下跌3.46%
证券之星 · 04-03
华恒生物（688639）披露2025年度股东会会议资料，4月3日股价下跌3.46%
华恒生物(688639.SH)发行H股获中国证监会备案
智通财经 · 04-02
华恒生物(688639.SH)发行H股获中国证监会备案
新股消息 | 华恒生物(688639.SH)港股IPO招股书失效
智通财经 · 03-30
新股消息 | 华恒生物(688639.SH)港股IPO招股书失效
每周股票复盘：华恒生物（688639）将召开2025年年度业绩说明会
证券之星 · 03-29
每周股票复盘：华恒生物（688639）将召开2025年年度业绩说明会
华恒生物（688639）披露2025年年度业绩说明会公告，3月26日股价下跌1.64%
证券之星 · 03-26
华恒生物（688639）披露2025年年度业绩说明会公告，3月26日股价下跌1.64%
3月23日华恒生物跌7.87%，交银先进制造混合A基金重仓该股
证券之星 · 03-23
3月23日华恒生物跌7.87%，交银先进制造混合A基金重仓该股
每周股票复盘：华恒生物（688639）2025年净利降30.13%
证券之星 · 03-22
每周股票复盘：华恒生物（688639）2025年净利降30.13%
华恒生物公布国际专利申请：“一种生产L-丝氨酸工程菌株、构建方法和应用”
证券之星 · 03-21
华恒生物公布国际专利申请：“一种生产L-丝氨酸工程菌株、构建方法和应用”
华恒生物（688639）2025年年报简析：增收不增利，公司应收账款体量较大
证券之星 · 03-19
华恒生物（688639）2025年年报简析：增收不增利，公司应收账款体量较大
华恒生物(688639.SH)发布2025年度业绩，归母净利润1.32亿元，同比下降30.13%
智通财经 · 03-17
华恒生物(688639.SH)发布2025年度业绩，归母净利润1.32亿元，同比下降30.13%
加载更多
公司概况
公司名称：
安徽华恒生物科技股份有限公司
所属行业：
化学原料和化学制品制造业
上市日期：
2021-04-22
主营业务：
安徽华恒生物科技股份有限公司的主营业务是生物基产品的研发、生产、销售。公司的主要产品是氨基酸系列产品、维生素系列产品、生物基新材料单体、其他产品。
发行价格：
23.16
{"stockData":{"symbol":"688639","market":"SH","secType":"STK","nameCN":"华恒生物","latestPrice":27.11,"timestamp":1778828401000,"preClose":26.1,"halted":0,"volume":7658268,"delay":0,"changeRate":0.0387,"floatShares":250000000,"shares":250000000,"eps":0.4935,"marketStatus":"已收盘","change":1.01,"latestTime":"05-15 15:00:01","open":26.08,"high":27.45,"low":25.92,"amount":205000000,"amplitude":0.0586,"askPrice":27.12,"askSize":20,"bidPrice":27.11,"bidSize":126,"shortable":0,"etf":0,"ttmEps":0.4935,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779067800000},"marketStatusCode":5,"adr":0,"adjPreClose":26.1,"symbolType":"stock_kcb","openAndCloseTimeList":[[1778808600000,1778815800000],[1778821200000,1778828400000]],"highLimit":28.71,"lowLimit":23.49,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":250115693,"isCdr":false,"pbRate":2.52,"roa":"--","peRate":54.934144,"roe":"1.58%","epsLYR":0.53,"committee":0.257485,"marketValue":6781000000,"turnoverRate":0.0306,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-05-18。","afterMarket":{"amount":32532,"volume":1200,"close":27.11,"buyVolume":0,"sellVolume":2800,"time":1778830437559,"indexStatus":"已收盘 05-15 15:30:00","preClose":26.1},"floatMarketCap":6781000000},"requestUrl":"/m/hq/s/688639/","defaultTab":"news","newsList":[{"id":"2634841453","title":"每周股票复盘：华恒生物（688639）推进H股上市进程","url":"https://stock-news.laohu8.com/highlight/detail?id=2634841453","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634841453?lang=zh_cn&edition=full","pubTime":"2026-05-10 02:22","pubTimestamp":1778350933,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，华恒生物报收于27.41元，较上周的28.0元下跌2.11%。本周，华恒生物5月6日盘中最高价报28.49元。华恒生物当前最新总市值68.56亿元，在化学制品板块市值排名67/171，在两市A股市值排名2819/5200。本周关注点公司公告汇总：华恒生物已更新H股上市申请材料并提交至香港联交所。公司公告汇总安徽华恒生物科技股份有限公司正在推进发行境外上市股份（H股）并在香港联合交易所主板上市的相关工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000000835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633839091","title":"华恒生物（688639）披露发行H股并上市进展公告，5月6日股价下跌1.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633839091","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633839091?lang=zh_cn&edition=full","pubTime":"2026-05-06 17:32","pubTimestamp":1778059975,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，华恒生物报收于27.7元，较前一交易日下跌1.07%，最新总市值为69.28亿元。该股当日开盘28.0元，最高28.49元，最低27.63元，成交额达1.55亿元，换手率为2.21%。安徽华恒生物科技股份有限公司于近日披露《关于发行H股并上市的进展公告》。公告显示，公司正在推进发行境外上市股份（H股）并在香港联合交易所主板上市的相关工作。本次发行尚需获得香港证监会及香港联交所等监管机构的批准，存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600027547.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632628370","title":"每周股票复盘：华恒生物（688639）每股派现0.16元（含税）","url":"https://stock-news.laohu8.com/highlight/detail?id=2632628370","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632628370?lang=zh_cn&edition=full","pubTime":"2026-05-02 05:16","pubTimestamp":1777670176,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，华恒生物报收于28.0元，较上周的27.82元上涨0.65%。本周，华恒生物4月30日盘中最高价报28.65元。本周关注点公司公告汇总：华恒生物每股派发现金红利0.16元（含税），股权登记日为2026年5月11日。本次利润分配以总股本250,115,693股扣减回购股份496,600股为基数，合计派发现金红利39,939,054.88元（含税）。截至核查意见出具日，总股本为250,115,693股，参与分配股份数量为249,619,093股。保荐机构兴业证券对此事项无异议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200002979.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632691162","title":"新股消息 | 华恒生物(688639.SH)递表港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2632691162","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632691162?lang=zh_cn&edition=full","pubTime":"2026-05-01 11:49","pubTimestamp":1777607350,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据港交所2026年4月30日披露，安徽华恒生物科技股份有限公司(简称：华恒生物(688639.SH))向港交所提交上市申请书，华泰国际为独家保荐人。招股书显示，华恒生物为全球首家实现系列氨基酸(包括L-丙氨酸及L-缬氨酸)厌氧发酵法产业化的企业，以2024年收入为衡量标准，公司L-丙氨酸及L-缬氨酸的市场份额分别位居全球第一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437607.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688639","IPOS","BK0229","HEXmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630802858","title":"每周股票复盘：华恒生物（688639）股东户数减少13.68%，一季报净利降17.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630802858","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630802858?lang=zh_cn&edition=full","pubTime":"2026-04-26 04:37","pubTimestamp":1777149428,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，华恒生物报收于27.82元，较上周的28.06元下跌0.86%。本周，华恒生物4月23日盘中最高价报29.66元。华恒生物当前最新总市值69.58亿元，在化学制品板块市值排名64/171，在两市A股市值排名2695/5200。本周关注点股本股东变化：股东户数较上期减少13.68%，户均持股上升至1.95万股。股本股东变化股东户数变动截至2026年3月31日，公司股东户数为1.28万户，较2月28日减少2035.0户，减幅13.68%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600001950.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629584046","title":"华恒生物（688639）2026年一季报简析：增收不增利，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2629584046","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629584046?lang=zh_cn&edition=full","pubTime":"2026-04-24 22:28","pubTimestamp":1777040923,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期华恒生物发布2026年一季报。截至本报告期末，公司营业总收入7.71亿元，同比上升12.26%，归母净利润4209.73万元，同比下降17.61%。本报告期华恒生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达199.82%。本次财报公布的各项数据指标表现一般。持有华恒生物最多的基金为招商安瑞进取债券A，目前规模为20.97亿元，最新净值2.6572，较上一交易日下跌0.77%，近一年上涨41.34%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400065156.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629026934","title":"华恒生物(688639.SH)发布一季度业绩，归母净利润4210万元，同比下降17.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629026934","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629026934?lang=zh_cn&edition=full","pubTime":"2026-04-23 00:27","pubTimestamp":1776875257,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华恒生物(688639.SH)披露2026年第一季度报告，报告期公司实现营收7.71亿元，同比增长12.26%;归母净利润4210万元，同比下降17.61%;扣非净利润4213万元，同比下降16.92%。基本每股收益0.17元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432313.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626193897","title":"新股消息 | 华恒生物(688639.SH)港股IPO获中国证监会备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2626193897","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626193897?lang=zh_cn&edition=full","pubTime":"2026-04-10 16:48","pubTimestamp":1775810926,"startTime":"0","endTime":"0","summary":"4月10日，中国证监会国际合作司发布《关于安徽华恒生物科技股份有限公司境外发行上市备案通知书》。华恒生物(688639.SH)拟发行不超过3195.93万股境外上市普通股并在香港联合交易所上市。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20260410/20260410164905_55771.png?x-oss-process=image/format,jpg/quality,q_60&image_source=0","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260410/20260410164905_55771.png?x-oss-process=image/format,jpg/quality,q_60&image_source=0"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427074.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4585","IPOS","VXUS","BK0229","688639","BK4588","SPCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625931292","title":"华恒生物（688639）披露2025年年度持续督导跟踪报告，4月7日股价上涨2.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625931292","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625931292?lang=zh_cn&edition=full","pubTime":"2026-04-07 18:15","pubTimestamp":1775556921,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘，华恒生物报收于28.48元，较前一交易日上涨2.96%，最新总市值为71.23亿元。该股当日开盘27.6元，最高28.83元，最低27.55元，成交额达1.12亿元，换手率为1.58%。近日，兴业证券股份有限公司发布《关于安徽华恒生物科技股份有限公司2025年年度持续督导跟踪报告》。公告显示，作为保荐机构，兴业证券对华恒生物2025年度持续督导情况进行报告。报告期内，公司营业收入同比增长31.40%，净利润同比下降30.13%，主要受产品价格下降及费用增加影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700025227.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625616411","title":"每周股票复盘：华恒生物（688639）获准发行H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2625616411","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625616411?lang=zh_cn&edition=full","pubTime":"2026-04-05 02:16","pubTimestamp":1775326573,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，华恒生物报收于27.66元，较上周的29.58元下跌6.49%。本周，华恒生物3月30日盘中最高价报30.48元。本周关注点来自公司公告汇总：华恒生物获中国证监会备案，拟发行不超过31,959,300股H股。公司已获得中国证监会关于发行不超过31,959,300股境外上市普通股（H股）并在港交所主板上市的备案通知书，有效期12个月。兴业证券发布持续督导报告指出，华恒生物2025年营业收入同比增长31.40%，净利润同比下降30.13%，主因产品价格下滑及费用上升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500000510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624665910","title":"华恒生物（688639）披露2025年度股东会会议资料，4月3日股价下跌3.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624665910","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624665910?lang=zh_cn&edition=full","pubTime":"2026-04-03 17:40","pubTimestamp":1775209228,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，华恒生物报收于27.66元，较前一交易日下跌3.46%，最新总市值为69.18亿元。该股当日开盘28.55元，最高28.86元，最低27.43元，成交额达1.42亿元，换手率为2.03%。近日，安徽华恒生物科技股份有限公司披露《2025年度股东会会议资料》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300034609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624576249","title":"华恒生物(688639.SH)发行H股获中国证监会备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2624576249","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624576249?lang=zh_cn&edition=full","pubTime":"2026-04-02 15:42","pubTimestamp":1775115744,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华恒生物(688639.SH)发布公告，公司正在进行申请发行境外上市股份(H股)并在香港联合交易所主板挂牌上市的相关工作。公司于近日收到中国证监会出具的《关于安徽华恒生物科技股份有限公司境外发行上市备案通知书》(国合函〔2026〕705号)。公司拟发行不超过3195.93万股境外上市普通股并在香港联合交易所上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424528.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0229","688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623653360","title":"新股消息 | 华恒生物(688639.SH)港股IPO招股书失效","url":"https://stock-news.laohu8.com/highlight/detail?id=2623653360","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623653360?lang=zh_cn&edition=full","pubTime":"2026-03-30 10:41","pubTimestamp":1774838474,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，安徽华恒生物科技股份有限公司于2025年9月30日所递交的港股招股书满6个月，于2026年3月30日失效，递表时华泰国际为独家保荐人。据招股书，作为全球合成生物技术的先行者，华恒生物专注于依托生物制造技术，开展生物基产品的研发、规模化生产和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421535.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688639","BK4588","BK0229","BK4585","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623386313","title":"每周股票复盘：华恒生物（688639）将召开2025年年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2623386313","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623386313?lang=zh_cn&edition=full","pubTime":"2026-03-29 03:15","pubTimestamp":1774725314,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，华恒生物报收于29.58元，较上周的31.26元下跌5.37%。本周，华恒生物3月23日盘中最高价报30.9元。本周关注点公司公告汇总：安徽华恒生物科技股份有限公司将于2026年03月31日召开2025年年度业绩说明会。公司公告汇总安徽华恒生物科技股份有限公司将于2026年03月31日10:00-11:00在上证路演中心召开2025年年度业绩说明会，通过网络互动方式与投资者交流年度经营成果及财务状况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900000690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622853594","title":"华恒生物（688639）披露2025年年度业绩说明会公告，3月26日股价下跌1.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622853594","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622853594?lang=zh_cn&edition=full","pubTime":"2026-03-26 17:24","pubTimestamp":1774517052,"startTime":"0","endTime":"0","summary":"截至2026年3月26日收盘，华恒生物报收于28.85元，较前一交易日下跌1.64%，最新总市值为72.16亿元。该股当日开盘29.18元，最高29.57元，最低28.7元，成交额达1.15亿元，换手率为1.58%。公告显示，公司将于2026年03月31日10:00-11:00在上证路演中心召开2025年年度业绩说明会，通过网络互动方式与投资者交流年度经营成果及财务状况。投资者可于2026年03月26日至03月30日16:00前通过上证路演中心网站或公司邮箱ahb@ehuaheng.com提交问题。说明会后可通过该平台查看会议内容。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032600031533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621577665","title":"3月23日华恒生物跌7.87%，交银先进制造混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2621577665","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621577665?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:42","pubTimestamp":1774255365,"startTime":"0","endTime":"0","summary":"证券之星消息，3月23日华恒生物跌7.87%创60日新低，收盘报28.8元，换手率3.59%，成交量8.99万手，成交额2.69亿元。重仓华恒生物的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级1家，增持评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为交银施罗德基金的交银先进制造混合A。交银先进制造混合A目前规模为42.23亿元，最新净值5.945，较上一交易日上涨0.48%，近一年上涨48.14%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300025452.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","399260","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621966796","title":"每周股票复盘：华恒生物（688639）2025年净利降30.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621966796","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621966796?lang=zh_cn&edition=full","pubTime":"2026-03-22 02:03","pubTimestamp":1774116195,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，华恒生物报收于31.26元，较上周的36.12元下跌13.46%。本周，华恒生物3月16日盘中最高价报36.88元。本周关注点来自业绩披露要点：华恒生物2025年归母净利润1.32亿元，同比下降30.13%。股本股东变化截至2026年2月28日，华恒生物股东户数为1.49万户，较2024年末增加2569户，增幅20.88%。2025年第四季度单季营收6.68亿元，同比增长4.6%；单季归母净利润亏损3520.94万元，同比下滑279.41%；单季扣非净利润亏损4743.67万元，同比下滑508.64%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000406.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621752753","title":"华恒生物公布国际专利申请：“一种生产L-丝氨酸工程菌株、构建方法和应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2621752753","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621752753?lang=zh_cn&edition=full","pubTime":"2026-03-21 05:54","pubTimestamp":1774043675,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示华恒生物（688639）公布了一项国际专利申请，专利名为“一种生产L-丝氨酸工程菌株、构建方法和应用”，专利申请号为PCT/CN2025/096916，国际公布日为2026年3月19日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来华恒生物已公布的国际专利申请1个。结合公司2025年年报财务数据，2025年公司在研发方面投入了1.51亿元，同比增21.89%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032100004171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620293364","title":"华恒生物（688639）2025年年报简析：增收不增利，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2620293364","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620293364?lang=zh_cn&edition=full","pubTime":"2026-03-19 06:02","pubTimestamp":1773871362,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期华恒生物发布2025年年报。截至本报告期末，公司营业总收入28.62亿元，同比上升31.4%，归母净利润1.32亿元，同比下降30.13%。本报告期华恒生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达204.85%。本次财报公布的各项数据指标表现一般。长期借款变动幅度为146.54%,原因:公司调整融资结构转为长期借款。营业收入变动幅度为31.4%,原因:公司氨基酸系列产品销量增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031900003207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620910424","title":"华恒生物(688639.SH)发布2025年度业绩，归母净利润1.32亿元，同比下降30.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620910424","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620910424?lang=zh_cn&edition=full","pubTime":"2026-03-17 20:14","pubTimestamp":1773749673,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华恒生物(688639.SH)发布2025年年度报告，报告期内，公司实现营业收入28.62亿元，同比增长31.40%。实现归属于上市公司股东的净利润1.32亿元，同比下降30.13%。实现归属于上市公司股东的扣除非经常性损益的净利润1.2亿元，同比下降32.56%。基本每股收益为0.53元。公司拟向全体股东每股派发现金红利0.16元(含税)。报告期内，公司主要产品缬氨酸、肌醇年平均价格较去年同期下降，且公司新项目效益尚未体现，对公司利润产生影响，同时，伴随公司经营规模扩大，公司各项费用较去年同期增加，公司归母净利润较去年同期减少0.57亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415052.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"华恒生物(688639.SH)发布2025年度业绩，归母净利润1.32亿元，同比下降30.13%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688639"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778909749169,"stockEarnings":[{"period":"1week","weight":-0.0052},{"period":"1month","weight":-0.0372},{"period":"3month","weight":-0.205},{"period":"6month","weight":-0.2981},{"period":"1year","weight":-0.0377},{"period":"ytd","weight":-0.1631}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.0131},{"period":"6month","weight":0.0363},{"period":"1year","weight":0.2232},{"period":"ytd","weight":0.042}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"安徽华恒生物科技股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"12837人(较上一季度减少13.68%)","perCapita":"19483股","listingDate":"2021-04-22","address":"安徽省合肥市长丰县双凤工业区","registeredCapital":"25011万元","survey":" 安徽华恒生物科技股份有限公司的主营业务是生物基产品的研发、生产、销售。公司的主要产品是氨基酸系列产品、维生素系列产品、生物基新材料单体、其他产品。","listedPrice":23.16},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华恒生物(688639)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华恒生物(688639)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华恒生物,688639,华恒生物股票,华恒生物股票老虎,华恒生物股票老虎国际,华恒生物行情,华恒生物股票行情,华恒生物股价,华恒生物股市,华恒生物股票价格,华恒生物股票交易,华恒生物股票购买,华恒生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华恒生物(688639)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华恒生物(688639)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}